GSK-VEG111485



VEG111485: A Phase I, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effect of Repeat Oral Doses of Pazopanib (GW786034) on Cardiac Conduction in Subjects with Solid Tumors
pazopanib
VEG111485
NCT00861029
Carcinoma, Renal Cell
Phase 1
 
May 2013